Department of Paediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2197-2210.e3. doi: 10.1016/j.cgh.2023.01.019. Epub 2023 Jan 31.
BACKGROUND & AIMS: Eosinophilic esophagitis (EoE) can be treated by proton pump inhibitors, topical corticosteroids, or dietary measures. This study systematically assessed the efficacy of 4 major dietary treatment regimens in EoE, updating the evidence presented in a meta-analysis from 2014.
Electronic databases such as PubMed, Scopus, and Web of Science, and other sources were searched up to September 2022 to identify studies on dietary treatment of EoE. Based on histologic remission criteria, the efficacy of these treatments was pooled and analyzed with respect to the type of dietary regimen: 6-food elimination diet (SFED), 4-food elimination diet (FFED), 1-food elimination diet (OFED), and a targeted elimination diet (TED). Clinical response rates, food sensitization, and efficacies for a pediatric subpopulation were calculated. Influencing variables on efficacies were estimated via meta-regression analyses.
Thirty-four studies with 1762 patients met the inclusion criteria. The overall rate of histologic remission was 53.8% (95% CI, 48.0%-59.6%), and in the individual dietary groups was 61.3% (95% CI, 53.0%-69.3%) for SFED, 49.4% (95% CI, 32.5%-66.3%) for FFED, 51.4% (95% CI, 42.6%-60.1%) for OFED, and 45.7% (95% CI, 32.0%-59.7%) for TED. Dietary regimen and patient age did not significantly affect rates of histologic remission. The overall rate of clinical response was 80.8% (95% CI, 72.3%-88.2%), with response rates of 92.8% (95% CI, 81.2%-99.6%) for SFED, 74.1% (95% CI, 49.8%-92.6%) for FFED, 87.1% (95% CI, 58.4%-99.9%) for OFED, and 69.0% (95% CI, 50.2%85.3%) for TED.
Dietary therapy is an effective treatment for EoE patients of any age. The current results could support a trend toward less-restrictive dietary regimens as a primary treatment option.
质子泵抑制剂、局部皮质类固醇或饮食措施可用于治疗嗜酸性食管炎(EoE)。本研究系统评估了 4 种主要饮食治疗方案在 EoE 中的疗效,更新了 2014 年荟萃分析中提出的证据。
截至 2022 年 9 月,我们通过电子数据库(如 PubMed、Scopus 和 Web of Science)和其他来源检索了有关 EoE 饮食治疗的研究。根据组织学缓解标准,汇总这些治疗方法的疗效,并根据饮食方案的类型进行分析:6 种食物排除饮食(SFED)、4 种食物排除饮食(FFED)、1 种食物排除饮食(OFED)和靶向排除饮食(TED)。计算了临床反应率、食物致敏性和儿科亚组的疗效。通过荟萃回归分析估计对疗效有影响的变量。
34 项研究纳入了 1762 名患者。组织学缓解的总体率为 53.8%(95%CI,48.0%-59.6%),在个别饮食组中,SFED 为 61.3%(95%CI,53.0%-69.3%),FFED 为 49.4%(95%CI,32.5%-66.3%),OFED 为 51.4%(95%CI,42.6%-60.1%),TED 为 45.7%(95%CI,32.0%-59.7%)。饮食方案和患者年龄均未显著影响组织学缓解率。临床反应的总体率为 80.8%(95%CI,72.3%-88.2%),SFED 为 92.8%(95%CI,81.2%-99.6%),FFED 为 74.1%(95%CI,49.8%-92.6%),OFED 为 87.1%(95%CI,58.4%-99.9%),TED 为 69.0%(95%CI,50.2%85.3%)。
饮食疗法是治疗任何年龄 EoE 患者的有效方法。目前的结果可能支持采用限制较少的饮食方案作为主要治疗选择的趋势。